Subscribe for unlimited access to DynaMed content, CME/CE & MOC credit, and email alerts on content you follow.

Already subscribed? Sign in now

Learn more about CME

Bipolar Disorder

General Information

Description

  • bipolar disorder is a mood disorder characterized by recurrent episodes of abnormally and persistently elevated, expansive, or irritable mood and alternating or intertwining episodes of major depression1, 2, 4
    • mood episodes are accompanied by changes in activity or energy and associated with cognitive, physical, and behavioral symptoms
    • bipolar I disorder characterized by ≥ 1 episode of mania, with or without psychosis and/or major depression
    • bipolar II disorder characterized by ≥ 1 episode of major depression and at least 1 hypomanic episode, without episodes of mania

Also called

  • manic disorder
  • manic affective disorder
  • manic-depressive disorder
  • affective disorder (manic type)

Definitions

  • Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5) delineates specifiers that describe certain additional clinical features of bipolar disorder, including
    • rapid cycling1, 2, 3, 4
      • characterized by ≥ 4 episodes in 12 months that meet criteria for manic, hypomanic, or major depressive disorder
      • episodes are interspersed with periods of partial or full remission for ≥ 2 months or a switch to episode of opposite polarity
      • appears associated with a more severe prognosis, frequent and prolonged episodes, increased deaths by suicide, and additional comorbidity
    • mixed features4
      • requires ≥ 3 symptoms from opposite pole that occur during depressive, hypomanic, or manic episodes
        • for example, during hypomanic or manic episode: depressed mood, anhedonia, fatigue, feeling of worthlessness, recurrent thoughts of death, or psychomotor retardation occurring nearly every day
        • for example, during depressive episode: elevated mood, inflated self-esteem or grandiosity, more talkative than usual, racing thoughts, increased goal-oriented activities, or decreased need for sleep
    • anxious distress4
      • applied to patients with anxiety symptoms not otherwise part of bipolar diagnostic criteria
      • requires ≥ 2 symptoms that occur during depressive, hypomanic, or manic episodes
      • includes symptoms, such as, feeling tense, feeling restless, difficulty concentrating due to worry, fear that something bad may happen, or feeling that the individual might lose control of himself or herself
    • psychotic features4, 6
      • delusions more common than hallucinations
      • delusions or hallucinations can be mood congruent (consistent with episode polarity) or mood incongruent (inconsistent with episode polarity)
      • may be used per DSM-5 to distinguish mania and bipolar I disorder from hypomania and bipolar II disorder
    • melancholic features4
      • characterized by loss of pleasure in all, or almost all, activities or lack of reactivity to normally pleasurable stimuli in most severe period of current episode
      • requires presence of ≥ 3 symptoms in most severe period of current episode
        • anorexia or significant weight loss
        • depressed mood with profound despair and/or moroseness
        • early morning awakening (≥ 2 hours before usual awakening)
        • excessive or inappropriate guilt
        • significant psychomotor agitation or retardation
        • worsened morning depression
    • atypical features4
      • characterized by predominating features during current or most recent depressive episode
        • mood reactivity
        • requires ≥ 2 symptoms that include
          • hypersomnia
          • leaden paralysis
          • significant social or occupational impairment due to pattern of sensitivity to interpersonal rejection
          • significant weight gain or increase in appetite
    • seasonal pattern4
      • characterized by regular seasonal patterning of at least 1 type of episode (mania, hypomania, or depressive episode) in last 2 years, with no nonseasonal episodes of that polarity
      • seasonal patterns involve regular temporal relationships between episode onset and time of year
      • lifetime number of seasonal episodes of that polarity significantly greater than nonseasonal episodes
    • catatonia - episode of mania or depression with catatonic features present during a majority of the episode4
  • mixed state2
    • term used previously in DSM-IV-TR to describe concurrent depressed mood plus increased energy, restlessness, and racing thoughts
    • required full symptomatic criteria for a major depressive and a manic episode for ≥ 1 week, as opposed to the specifier in DSM-5, mixed features, which requires only 3 or more symptoms from opposite pole during the majority of days during the current episode
    • Reference - World J Biol Psychiatry 2018 Feb;19(1):2

Types

  • bipolar spectrum disorders categorized in Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5) include1, 4
    • bipolar I disorder, characterized by at least 1 episode of mania or mixed episode with or without psychosis and/or major depression
    • bipolar II disorder, characterized by at least 1 episode of major depression and 1 hypomanic episode (not mania or mixed episode)
    • cyclothymic disorder, characterized by periods with hypomanic and depressive symptoms that do not meet criteria for hypomanic episode or major depression for at least 2 years
    • other specified bipolar and related disorder, characterized by bipolar-like disorders that do not meet criteria for bipolar I disorder, bipolar II disorder, or cyclothymia because of insufficient duration or severity
    • unspecified bipolar and related disorder, characterized by symptoms of bipolar and related disorders that do not meet full criteria for any category previously mentioned
    • substance/medication-induced bipolar and related disorder, in which mood disorder developed after substance intoxication or withdrawal, or after exposure to a medication capable of producing symptoms
    • bipolar and related disorder due to another medical condition, in which mood disorder developed as a direct pathophysiological consequence of another medical condition based on evidence from the history, physical examination, or laboratory findings

References

General references used

  1. Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016 Apr 9;387(10027):1561-72, commentary can be found in Lancet 2016 Aug 27;388(10047):868 and Lancet 2016 Aug 27;388(10047):869
  2. Price AL, Marzani-Nissen GR. Bipolar disorders: a review. Am Fam Physician. 2012 Mar 1;85(5):483-93full-text
  3. Saunders KE, Geddes JR. The management of bipolar disorder. Br J Hosp Med (Lond). 2016 Mar;77(3):175-9
  4. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018 Mar;20(2):97-170full-text
  5. National Institute for Health and Clinical Excellence (NICE). Bipolar disorder: assessment and management. NICE 2014 Sep:CG185PDF
  6. Mohammad O, Osser DN. The psychopharmacology algorithm project at the Harvard South Shore Program: an algorithm for acute mania. Harv Rev Psychiatry. 2014 Sep-Oct;22(5):274-94
  7. Ansari A, Osser DN. The psychopharmacology algorithm project at the Harvard South Shore Program: an update on bipolar depression. Harv Rev Psychiatry. 2010 Jan-Feb;18(1):36-55

Recommendation grading systems used

  • American Psychiatric Association (APA) categories of recommendation
    • Category I - recommended with substantial clinical confidence
    • Category II - recommended with moderate clinical confidence
    • Category III - may be recommended on the basis of individual circumstances
    • Reference - APA 2010 practice guideline on treatment of patients with major depressive disorder, third edition (APA 2010 Nov PDF)

Synthesized Recommendation Grading System for DynaMed Content

  • The DynaMed Team systematically monitors clinical evidence to continuously provide a synthesis of the most valid relevant evidence to support clinical decision-making (see 7-Step Evidence-Based Methodology).
  • Guideline recommendations summarized in the body of a DynaMed topic are provided with the recommendation grading system used in the original guideline(s), and allow users to quickly see where guidelines agree and where guidelines differ from each other and from the current evidence.
  • In DynaMed content, we synthesize the current evidence, current guidelines from leading authorities, and clinical expertise to provide recommendations to support clinical decision-making in the Overview & Recommendations section.
  • We use the Grading of Recommendations Assessment, Development and Evaluation (GRADE) to classify synthesized recommendations as Strong or Weak.
    • Strong recommendations are used when, based on the available evidence, clinicians (without conflicts of interest) consistently have a high degree of confidence that the desirable consequences (health benefits, decreased costs and burdens) outweigh the undesirable consequences (harms, costs, burdens).
    • Weak recommendations are used when, based on the available evidence, clinicians believe that desirable and undesirable consequences are finely balanced, or appreciable uncertainty exists about the magnitude of expected consequences (benefits and harms). Weak recommendations are used when clinicians disagree in judgments of relative benefit and harm, or have limited confidence in their judgments. Weak recommendations are also used when the range of patient values and preferences suggests that informed patients are likely to make different choices.
  • DynaMed synthesized recommendations (in the Overview & Recommendations section) are determined with a systematic methodology:
    • Recommendations are initially drafted by clinical editors (including ≥ 1 with methodological expertise and ≥ 1 with content domain expertise) aware of the best current evidence for benefits and harms, and the recommendations from guidelines.
    • Recommendations are phrased to match the strength of recommendation. Strong recommendations use "should do" phrasing, or phrasing implying an expectation to perform the recommended action for most patients. Weak recommendations use "consider" or "suggested" phrasing.
    • Recommendations are explicitly labeled as Strong recommendations or Weak recommendations when a qualified group has explicitly deliberated on making such a recommendation. Group deliberation may occur during guideline development. When group deliberation occurs through DynaMed Team-initiated groups:
      • Clinical questions will be formulated using the PICO (Population, Intervention, Comparison, Outcome) framework for all outcomes of interest specific to the recommendation to be developed.
      • Systematic searches will be conducted for any clinical questions where systematic searches were not already completed through DynaMed content development.
      • Evidence will be summarized for recommendation panel review including for each outcome, the relative importance of the outcome, the estimated effects comparing intervention and comparison, the sample size, and the overall quality rating for the body of evidence.
      • Recommendation panel members will be selected to include at least 3 members that together have sufficient clinical expertise for the subject(s) pertinent to the recommendation, methodological expertise for the evidence being considered, and experience with guideline development.
      • All recommendation panel members must disclose any potential conflicts of interest (professional, intellectual, and financial), and will not be included for the specific panel if a significant conflict exists for the recommendation in question.
      • Panel members will make Strong recommendations if and only if there is consistent agreement in a high confidence in the likelihood that desirable consequences outweigh undesirable consequences across the majority of expected patient values and preferences. Panel members will make Weak recommendations if there is limited confidence (or inconsistent assessment or dissenting opinions) that desirable consequences outweigh undesirable consequences across the majority of expected patient values and preferences. No recommendation will be made if there is insufficient confidence to make a recommendation.
      • All steps in this process (including evidence summaries which were shared with the panel, and identification of panel members) will be transparent and accessible in support of the recommendation.
    • Recommendations are verified by ≥ 1 editor with methodological expertise, not involved in recommendation drafting or development, with explicit confirmation that Strong recommendations are adequately supported.
    • Recommendations are published only after consensus is established with agreement in phrasing and strength of recommendation by all editors.
    • If consensus cannot be reached then the recommendation can be published with a notation of "dissenting commentary" and the dissenting commentary is included in the topic details.
    • If recommendations are questioned during peer review or post publication by a qualified individual, or reevaluation is warranted based on new information detected through systematic literature surveillance, the recommendation is subject to additional internal review.

DynaMed Editorial Process

  • DynaMed topics are created and maintained by the DynaMed Editorial Team and Process.
  • All editorial team members and reviewers have declared that they have no financial or other competing interests related to this topic, unless otherwise indicated.
  • DynaMed content includes Practice-Changing Updates, with support from our partners, McMaster University and F1000.

Special acknowledgements

  • The American College of Physicians (Marjorie Lazoff, MD, FACP; ACP Deputy Editor, Clinical Decision Resource) provided review in a collaborative effort to ensure DynaMed provides the most valid and clinically relevant information in internal medicine.
  • DynaMed topics are written and edited through the collaborative efforts of the above individuals. Deputy Editors, Section Editors, and Topic Editors are active in clinical or academic medical practice. Recommendations Editors are actively involved in development and/or evaluation of guidelines.
  • Editorial Team role definitions
    Topic Editors define the scope and focus of each topic by formulating a set of clinical questions and suggesting important guidelines, clinical trials, and other data to be addressed within each topic. Topic Editors also serve as consultants for the internal DynaMed Editorial Team during the writing and editing process, and review the final topic drafts prior to publication.
    Section Editors have similar responsibilities to Topic Editors but have a broader role that includes the review of multiple topics, oversight of Topic Editors, and systematic surveillance of the medical literature.
    Recommendations Editors provide explicit review of Overview and Recommendations sections to ensure that all recommendations are sound, supported, and evidence-based. This process is described in "Synthesized Recommendation Grading."
    Deputy Editors oversee DynaMed internal publishing groups. Each is responsible for all content published within that group, including supervising topic development at all stages of the writing and editing process, final review of all topics prior to publication, and direction of an internal team.

How to cite

National Library of Medicine, or "Vancouver style" (International Committee of Medical Journal Editors):

  • DynaMed [Internet]. Ipswich (MA): EBSCO Information Services. 1995 - . Record No. T114738, Bipolar Disorder; [updated 2018 Dec 05, cited place cited date here]. Available from https://www.dynamed.com/topics/dmp~AN~T114738. Registration and login required.

top

Subscribe for unlimited access to DynaMed content.
Already subscribed? Sign in